+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Seborrhea Drug"

Seborrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Seborrhea - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Seborrhea - Pipeline Inisght, 2021 - Product Thumbnail Image

Seborrhea - Pipeline Inisght, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
From
Seborrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Seborrhea - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Seborrhea - Pipeline Review, H2 2020 - Product Thumbnail Image

Seborrhea - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 50 Pages
  • Global
From
Seborrhea Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Seborrhea Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • August 2020
  • 89 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

The Seborrhea Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Seborrhea Drugs are used to treat seborrheic dermatitis, a chronic skin condition characterized by red, scaly patches on the scalp, face, and other areas of the body. These drugs are typically topical medications, such as creams, ointments, and shampoos, and may contain active ingredients such as coal tar, salicylic acid, and corticosteroids. Seborrhea Drugs are available both over-the-counter and by prescription, and are used to reduce inflammation, itching, and scaling associated with seborrheic dermatitis. In addition, these drugs may be used to treat other skin conditions, such as psoriasis and eczema. Some companies in the Seborrhea Drug market include GlaxoSmithKline, Pfizer, Johnson & Johnson, Merck, and Novartis. Show Less Read more